fda ruling on semaglutide September 2, 2025: U.S. compounding restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines Federal judge upholds FDA's removal

Our medical professionals will discuss the total duration of your skin brightening treatment during your initial consultation

In this Q&A, Richard Frank, MD, MHSA, Chief Medical Officer at Vida, breaks down what the data actually shows: Oral and injectable semaglutides deliver similar weight loss, safety, and side-effect profiles, with both averaging around 15% weight reduction over more than a year

Those are: shifting demographics, digital coexistence, human security, and community

H.PangJ

Unacclimatized people, including tourists, new arrivals, and indoor workers stepping outside for the first time, lose even more